Chronicle Journal: Finance

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Lipocine Inc (NQ: LPCN)
0.4210 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 5:47 PM EDT, Apr 2, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 0.4210
Bid (Size) 0.4000 (11)
Ask (Size) 0.4400 (150)
Prev. Close 0.4210
Today's Range 0.4210 - 0.4210
52wk Range 0.3000 - 3.450
Shares Outstanding 21,264,539
Dividend Yield N/A
Performance
YTD
+0.24%
+0.24%
1 Month
-22.04%
-22.04%
3 Month
+0.24%
+0.24%
6 Month
-84.46%
-84.46%
1 Year
-81.77%
-81.77%
Top News
More News
Lipocine Announces Outcome of Markman Hearing in Patent Infringement Suit Against Clarus
Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that Judge William C. Bryson of the United States District Court... Read More
from PR Newswire
Lipocine Announces 2019 Year End Financial and Operational Results
Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company, today announced financial results for the year ended December 31, 2019, and provided a corporate update. Read More
from PR Newswire
More News
Read More
Lipocine Announces TLANDO™ PDUFA Date of August 28, 2020
from PR Newswire
Lipocine Announces Closing Of Registered Direct Offering Of Common Stock And Warrants
from PR Newswire
Lipocine Announces $6 Million Registered Direct Offering Priced At-The-Market
from PR Newswire
Lipocine Announces Regulatory Path Forward for TLANDO™ Resubmission
from PR Newswire
Lipocine Streamlines Its Infringement Lawsuit Against Clarus Therapeutics
from PR Newswire
Will These Penny Stocks Make New Highs This Week?
from Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
NetworkNewsBreaks – Lipocine Inc. (NASDAQ: LPCN) Secures $6 Million in Registered Direct
from InvestorBrandNetwork
LPCN FINAL DEADLINE TODAY: Rosen, a Leading Law Firm, Reminds Lipocine Inc. Investors of Important January 14th Deadline in Securities Class Action – LPCN
from GlobeNewswire News Releases
TUESDAY DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Lipocine, Inc. and Encourages Investors to Contact the Firm
from GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]